New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.

Glycosphingolipid lysosomal storage diseases are a small but challenging group of human disorders to treat. Although these appear to be monogenic disorders where the catalytic activity of enzymes in glycosphingolipid catabolism is impaired, the presentation and severity of disease is heterogeneous....

書誌詳細
主要な著者:	Butters, T, Dwek, R, Platt, F
フォーマット:	Journal article
言語:	English
出版事項:	2003

類似資料

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
著者:: Jeyakumar, M, 等
出版事項: (2002)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
著者:: Butters, T, 等
出版事項: (2000)

Substrate deprivation: a new therapeutic approach for the glycosphingolipid lysosomal storage diseases.
著者:: Platt, F, 等
出版事項: (2000)

New developments in treating glycosphingolipid storage diseases.
著者:: Platt, F, 等
出版事項: (2005)

Glycosphingolipid profiling of tissues from mouse models of human lysosomal storage disorders
著者:: Priestman, D, 等
出版事項: (2008)

Lysosomal storage of oligosaccharide and glycosphingolipid in imino sugar treated cells.
著者:: Boomkamp, S, 等
出版事項: (2010)

Therapeutic applications of imino sugars in lysosomal storage disorders.
著者:: Butters, T, 等
出版事項: (2003)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases
著者:: Silk, J, 等
出版事項: (2005)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.
著者:: Gadola, S, 等
出版事項: (2006)

Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders.
著者:: Butters, T, 等
出版事項: (2003)

Storage solutions: treating lysosomal disorders of the brain.
著者:: Jeyakumar, M, 等
出版事項: (2005)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
著者:: Andersson, U, 等
出版事項: (2000)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
著者:: Butters, T, 等
出版事項: (2005)

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
著者:: Butters, T, 等
出版事項: (2005)

Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesis.
著者:: Mellor, H, 等
出版事項: (2004)

Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.
著者:: Garner, B, 等
出版事項: (2002)

The development and use of small molecule inhibitors of glycosphingolipid metabolism for lysosomal storage diseases
著者:: James A. Shayman, 等
出版事項: (2014-07-01)

Substrate reduction therapy for glycosphingolipid storage disorders.
著者:: Lachmann, R, 等
出版事項: (2001)

Pharmacological impairment of acrosome formation and sperm head morphogenesis reveals essential role of glycosphingolipids in spermiogenesis
著者:: van der Spoel, A, 等
出版事項: (2002)

Glycosphingolipid dysregulation and lysosomal dysfunction in motor neuron disease
著者:: da Silva Santos, CS
出版事項: (2021)

ALTERED AUTOPHAGY AND APP METABOLISM IN GLYCOSPHINGOLIPID STORAGE DISEASES
著者:: Boland, B, 等
出版事項: (2011)

Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis
著者:: Butters, T, 等
出版事項: (2000)

Changes in glycosphingolipid levels in plasma and cerebrospinal fluid of individuals with Lysosomal Free Sialic Acid Storage Disorder
著者:: Marya S. Sabir, 等
出版事項: (2025-01-01)

Glycosphingolipid disorders of the brain.
著者:: Boomkamp, S, 等
出版事項: (2008)

Lysosomal dysfunction and glycosphingolipid dysregulation in rare and common neurodegenerative diseases
著者:: Huebecker, M
出版事項: (2019)

Introduction: Glycosphingolipids in cell biology and disease.
著者:: Sillence, D, 等
出版事項: (2004)

Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling.
著者:: Neville, D, 等
出版事項: (2004)

Lysosomal storage diseases
著者:: Platt, F, 等
出版事項: (2018)

Glycosphingolipids and Infection. Potential New Therapeutic Avenues
著者:: Johannes M. F. G. Aerts, 等
出版事項: (2019-12-01)

Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases.
著者:: Lloyd-Evans, E, 等
出版事項: (2011)

Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport.
著者:: te Vruchte, D, 等
出版事項: (2004)

Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice.
著者:: te Vruchte, D, 等
出版事項: (2010)

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy.
著者:: Platt, F, 等
出版事項: (2001)

Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice.
著者:: Garner, B, 等
出版事項: (2002)

Emptying the stores: lysosomal diseases and therapeutic strategies
著者:: Platt, F
出版事項: (2017)

Glycosphingolipids in endocytic membrane transport.
著者:: Sillence, D, 等
出版事項: (2004)

Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.
著者:: Pei, B, 等
出版事項: (2011)

Pharmacotherapeutic strategies using small molecules for the treatment of glycolipid lysosomal storage disorders.
著者:: Butters, T
出版事項: (2007)

Therapeutic Approaches in Lysosomal Storage Diseases
著者:: Carlos Fernández-Pereira, 等
出版事項: (2021-11-01)

The apo E gene knockout mouse as a model to study the potential atherogenic properties of glycosphingolipids
著者:: Garner, B, 等
出版事項: (2003)